Sign in

CIK 0001785530

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823523180
Phone
+1 617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-04 Flynn James E 10% owner Purchase +800,000 $16.00 $12.8M 2,552,787
2021-05-04 Flynn James E 10% owner Conversion · Series B Preferred Stock −15,195,094 0
2021-05-04 Sphera Global Healthcare Management LP 10% owner Conversion +312,997 312,997
2021-05-04 Sphera Global Healthcare Management LP 10% owner Purchase +475,000 $16.00 $7.6M 787,997
2021-05-04 Sphera Global Healthcare Management LP 10% owner Conversion · Series B Preferred Stock −2,713,410 0
2021-05-04 Arkin Bio Ventures 2 L.P. 10% owner Conversion +1,235,917 1,235,917
2021-05-04 Arkin Bio Ventures 2 L.P. 10% owner Conversion +410,717 1,646,634
2021-05-04 Arkin Bio Ventures 2 L.P. 10% owner Purchase +400,000 $16.00 $6.4M 2,046,634
2021-05-04 Arkin Bio Ventures 2 L.P. 10% owner Conversion · Series A Preferred Stock −10,714,284 0
2021-05-04 Arkin Bio Ventures 2 L.P. 10% owner Conversion · Series B Preferred Stock −3,560,551 0
2021-05-04 Taiho Ventures LLC 10% owner Conversion +1,318,311 1,318,311
2021-05-04 Taiho Ventures LLC 10% owner Conversion +438,098 1,756,409
2021-05-04 Taiho Ventures LLC 10% owner Purchase +312,500 $16.00 $5.0M 2,068,909
2021-05-04 Taiho Ventures LLC 10% owner Conversion · Series A Preferred Stock −11,428,570 0
2021-05-04 Taiho Ventures LLC 10% owner Conversion · Series B Preferred Stock −3,797,921 0
2021-05-04 Asanuma Sakae Director Conversion +1,318,311 1,318,311
2021-05-04 Asanuma Sakae Director Conversion +438,098 1,756,409
2021-05-04 Asanuma Sakae Director Purchase +312,500 $16.00 $5.0M 2,068,909
2021-05-04 Asanuma Sakae Director Conversion · Series A Preferred Stock −11,428,570 0
2021-05-04 Asanuma Sakae Director Conversion · Series B Preferred Stock −3,797,921 0

Page 15 of 17 · 335 trades